Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression
Sponsor: Chinese PLA General Hospital
Summary
This project employs a prospective, randomized, controlled, blinded, dual-center study design to investigate the effects of intraoperative esketamine on perioperative anxiety and depression symptoms in patients with severe depression undergoing breast cancer surgery.
Official title: Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
242
Start Date
2026-01-18
Completion Date
2027-02-01
Last Updated
2026-01-28
Healthy Volunteers
No
Conditions
Interventions
Esketamine 0.3mg/kg
A single intravenous bolus of 0.3 mg/kg of esketamine is administered during anesthesia induction, and the infusion is completed over 40 minutes.
normal saline
Receiving the same volume of normal saline during induction of anesthesia.